Page 9 - Stephen Schultz News Today

Study demonstrates feasibility of simultaneous administration of COMP360 psilocybin in a controlled setting to healthy participants with 1:1 therapist support London, UK - 4 January 2022

Investegate announcements from COMPASS Pathways, COMPASS Selected for Addition to NASDAQ Biotechnology Index

London, U.K., Dec. 17, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health

Investegate announcements from COMPASS Pathways, COMPASS Pathways announces changes in Executive Team

London, UK - 3 December 2021 COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced

Investegate announcements from COMPASS Pathways, Michael Falvey joins COMPASS Pathways as Chief Financial Officer

Investegate announcements from COMPASS Pathways, COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression

- Positive topline results validated by additional analyses - Patient improvements beyond reduction of depression symptoms - Further insights into timing and circumstance of adverse events demonstrate

In the opinion of the Canyonlands chapter of the Backcountry Horsemen, the reason Moab was originally founded is because of a geographic oddity: the Moab fault, which created an accessible

London, UK - 23 November 2021 COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced